|
We are delighted to announce a fully funded training course for PhD students on the art of science communication, providing students with the tools to present and discuss their work with a variety of audiences. We see this as a key skill which will raise the profile of rare diseases and rare cancers, and enable relationships with patient groups to flourish. |
|
|
The course is designed to help you achieve your goals - from perfecting a conference talk to speaking with patient groups, inspiring the next generation to facilitating dialogue between disparate groups.
PHD STUDENTS IN THE FIELDS OF BHD OR OSTEOSARCOMA ARE ELIGIBLE TO APPLY
|
|
How does the course work?
|
|
SESSION 1: How do we talk about our work?
How can we change our presentation style and content for different audiences, and structure our talks to achieve different things?
SESSION 2: Sharing results, data and insights
How to structure information so that the key insights are passed across.
How to design information for audiences that mix experts and non-experts.
How to design slides so that they put across the message you want them to.
SESSION 3: Online vs in-person presentation
How to use your voice and body to get your message across in-person.
How technology can help you do the same online, including how to minimise “Zoom fatigue” and distraction in you and your audience.
SESSION 4: Presentation Practice
You’ll get a chance to do a presentation to show off your new skills and get feedback from the group on how you can develop even further.
|
|
Places are limited. To apply, please send your CV and a cover letter outlining how you would benefit from the training to contact@myrovlytistrust.org with the subject heading ‘Science Communication Training Course Application’. The deadline for applications is 25th February 2022.
Students on the course will be provided with opportunities to use their newly acquired skills upon completion.
If you have any questions regarding the training course or the application, please contact us at the email address above.
|
|
PLEASE FORWARD THIS EMAIL TO INTERESTED PARTIES
|
|
|
|
|